Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaclyn F Hechtman

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2015
A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung CancerAlexander Drilon, Romel Somwar, Jacob P Wagner, et al.
Nature Communications|January 2, 2025
A deep multiple instance learning framework improves microsatellite instability detection from tumor next generation sequencingJohn Ziegler, Jaclyn F Hechtman, Satshil Rana, et al.
The American Journal of Surgical Pathology|March 20, 2018
NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of FibrosarcomaSarah Chiang, Paolo Cotzia, David M Hyman, et al.
JCO Precision Oncology|February 9, 2022
Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived XenograftsRyan H Moy, Henry S Walch, Marissa Mattar, et al.
Gynecologic Oncology|November 13, 2025
Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinomaRachel L Furuya, Whitney Grither, Mark G Evans, et al.
Cancer Research|January 16, 2019
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase FusionsEmiliano Cocco, Jamal Benhamida, Sumit Middha, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2023
Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 InactivationSoo-Ryum Yang, Erika Gedvilaite, Ryan Ptashkin, et al.
Familial Cancer|October 9, 2020
Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologiesMonika Vyas, Canan Firat, Jaclyn F Hechtman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2019
Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric CancerMegan Greally, Joanne F Chou, Walid K Chatila, et al.
Cancer Medicine|September 11, 2019
Genomic stratification beyond Ras/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusionJ Joshua Smith, Walid K Chatila, Francisco Sanchez-Vega, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2015
A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung CancerAlexander Drilon, Romel Somwar, Jacob P Wagner, et al.
Nature Communications|January 2, 2025
A deep multiple instance learning framework improves microsatellite instability detection from tumor next generation sequencingJohn Ziegler, Jaclyn F Hechtman, Satshil Rana, et al.
The American Journal of Surgical Pathology|March 20, 2018
NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of FibrosarcomaSarah Chiang, Paolo Cotzia, David M Hyman, et al.
JCO Precision Oncology|February 9, 2022
Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived XenograftsRyan H Moy, Henry S Walch, Marissa Mattar, et al.
Gynecologic Oncology|November 13, 2025
Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinomaRachel L Furuya, Whitney Grither, Mark G Evans, et al.
Cancer Research|January 16, 2019
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase FusionsEmiliano Cocco, Jamal Benhamida, Sumit Middha, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2023
Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 InactivationSoo-Ryum Yang, Erika Gedvilaite, Ryan Ptashkin, et al.
Familial Cancer|October 9, 2020
Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologiesMonika Vyas, Canan Firat, Jaclyn F Hechtman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2019
Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric CancerMegan Greally, Joanne F Chou, Walid K Chatila, et al.
Cancer Medicine|September 11, 2019
Genomic stratification beyond Ras/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusionJ Joshua Smith, Walid K Chatila, Francisco Sanchez-Vega, et al.
Pageof 12